title: State-of-the-Art Advances in Radiation Biodosimetry for Mass Casualty Events Involving Radiation Exposure.
abstract: With the possibility of large-scale terrorist attacks around the world, the need for modeling and development of new medical countermeasures for potential future chemical, biological, radiological and nuclear (CBRN) has been well established. Project Bioshield, initiated in 2004, provided a framework to develop and expedite research in the field of CBRN exposures. To respond to large-scale population exposures from a nuclear event or radiation dispersal device (RDD), new methods for determining received dose using biological modeling became necessary. The field of biodosimetry has advanced significantly beyond this original initiative, with expansion into the fields of genomics, proteomics, metabolomics and transcriptomics. Studies are ongoing to evaluate the use of lymphocyte kinetics for dose assessment, as well as the development of field-deployable EPR technology. In addition, expansion of traditional cytogenetic assessment methods through the use of automated platforms and the development of laboratory surge capacity networks have helped to advance our biodefense preparedness. In this review of the latest advances in the field of biodosimetry we evaluate our progress and identify areas that still need to be addressed to achieve true field-deployment readiness.
authors.affiliation: Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland.
authors.forename: Mary
authors.initials: M
authors.lastname: Sproull
authors.affiliation: Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland.
authors.forename: Kevin
authors.initials: K
authors.lastname: Camphausen
mesh_terms: D019295:Computational Biology; D020732:Cytogenetic Analysis; D006801:Humans; D008214:Lymphocytes / Q000166:cytology / Q000528:radiation effects; D054527:Mass Casualty Incidents; D000069079:Radiation Exposure / Q000009:adverse effects / Q000032:analysis*; D011874:Radiometry / Q000379:methods*